Digital Biomanufacturing Market Size, Share & Trends Analysis Report By Application (Biomanufacturing Process Automation and Control, Bioprocess Optimization and Process Analytics, Flexible Manufacturing), By Technology, Deployment option, By End-User, Region And Segment Forecasts, 2023-2031

Report Id: 1296 Pages: 180 Last Updated: 30 September 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Digital Biomanufacturing Market-

By Application -

  • Biomanufacturing Process Automation and Control
  • Bioprocess Optimization and Process Analytics
  • Flexible Manufacturing

digital biomanufacturing

By End-user-

  • Biopharmaceutical Companies
  • Academic and Research Institutes

By Deployment Option-

  • Cloud-based
  • On-premises

By Technology-

  • AI and IoMT Solutions
  • Process Analytical Technologies
  • Data Analytics Software
  • Predictive Analytics and Digital Twin Technologies
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

Chapter 1.          Methodology and Scope

1.1.        Research Methodology

1.2.        Research Scope & Assumptions

Chapter 2.          Executive Summary

Chapter 3.          Global Digital Biomanufacturing Market Snapshot

Chapter 4.          Global Digital Biomanufacturing Market Variables, Trends & Scope

4.1.        Market Segmentation & Scope

4.2.        Drivers

4.3.        Challenges

4.4.        Trends

4.5.        Investment and Funding Analysis

4.6.        Porter's Five Forces Analysis

4.7.        Incremental Opportunity Analysis (US$ MN), 2024-2031

4.8.        Global Digital Biomanufacturing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031

4.9.        Competitive Landscape & Market Share Analysis, By Key Player (2023)

4.10.     Use/impact of AI on Digital Biomanufacturing Market Industry Trends

Chapter 5.          Market Segmentation 1: By Technology, Estimates & Trend Analysis

5.1.        By Technology, & Market Share, 2023 & 2031

5.2.        Market Size (Value US$ Mn & Volume Unit) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:

5.2.1.    AI and IoMT Solutions

5.2.2.    Process Analytical Technologies

5.2.3.    Data Analytics Software

5.2.4.    Predictive Analytics and Digital Twin Technologies

5.2.5.    Others

Chapter 6.          Market Segmentation 2: By Application Estimates & Trend Analysis

6.1.        By Application & Market Share, 2023 & 2031

6.2.        Market Size (Value US$ Mn & Volume Unit) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:

6.2.1.    Biomanufacturing Process Automation and Control

6.2.2.    Bioprocess Optimization and Process Analytics

6.2.3.    Flexible Manufacturing

Chapter 7.          Market Segmentation 3: By End-user Estimates & Trend Analysis

7.1.        By End-user & Market Share, 2023 & 2031

7.2.        Market Size (Value US$ Mn & Volume Unit) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-user:

7.2.1.    Biopharmaceutical Companies

7.2.2.    Academic and Research Institutes

Chapter 8.          Market Segmentation 4: By Deployment Options Estimates & Trend Analysis

8.1.        By Deployment Options & Market Share, 2023 & 2031

8.2.        Market Size (Value US$ Mn & Volume Unit) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Deployment Options:

8.2.1.    Cloud-based

8.2.2.    On-premises

Chapter 9.          Market Segmentation 5: By Type(s) of Biologic(s)Manufactured Estimates & Trend Analysis

9.1.        By Type(s) of Biologic(s)Manufactured & Market Share, 2023 & 2031

9.2.        Market Size (Value US$ Mn & Volume Unit) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type(s) of Biologic(s)Manufactured:

9.2.1.    Antibodies

9.2.2.    Cell and Gene Therapies

9.2.3.    Proteins

9.2.4.    Vaccines

9.2.5.    Others

Chapter 10.        Digital Biomanufacturing Market Segmentation 6: Regional Estimates & Trend Analysis

10.1.     Global Digital Biomanufacturing Market, Regional Snapshot 2023 & 2031

10.2.     North America

10.2.1.  North America Digital Biomanufacturing Market Revenue (US$ Million) & Volume (Unit) Estimates and Forecasts by Country, 2019-2031

10.2.1.1.             US

10.2.1.2.             Canada

10.2.2.  North America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Technology, 2019-2031

10.2.3.  North America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Application, 2019-2031

10.2.4.  North America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By End-user, 2019-2031

10.2.5.  North America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Deployment Options, 2019-2031

10.2.6.  North America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Type(s) of Biologic(s)Manufactured, 2019-2031

10.3.     Europe

10.3.1.  Europe Digital Biomanufacturing Market Revenue (US$ Million) & Volume (Unit) Estimates and Forecasts by Country, 2019-2031

10.3.1.1.             Germany

10.3.1.2.             U.K.

10.3.1.3.             France

10.3.1.4.             Italy

10.3.1.5.             Spain

10.3.1.6.             Rest of Europe

10.3.2.  Europe Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Technology, 2019-2031

10.3.3.  Europe Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Application, 2019-2031

10.3.4.  Europe Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By End-user, 2019-2031

10.3.5.  Europe Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Deployment Options, 2019-2031

10.3.6.  Europe Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Type(s) of Biologic(s)Manufactured, 2019-2031

Asia Pacific

10.3.7.  Asia Pacific Digital Biomanufacturing Market Revenue (US$ Million) & Volume (Unit) Estimates and Forecasts by Country, 2019-2031

10.3.7.1.             India

10.3.7.2.             China

10.3.7.3.             Japan

10.3.7.4.             Australia

10.3.7.5.             South Korea

10.3.7.6.             Hong Kong

10.3.7.7.             Southeast Asia

10.3.7.8.             Rest of Asia Pacific

10.3.8.  Asia Pacific Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Technology, 2019-2031

10.3.9.  Asia Pacific Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Application, 2019-2031

10.3.10.              Asia Pacific Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By End-user, 2019-2031

10.3.11.              Asia Pacific Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Deployment Options, 2019-2031

10.3.12.              Asia Pacific Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Type(s) of Biologic(s)Manufactured, 2019-2031

10.4.     Latin America

10.4.1.  Latin America Digital Biomanufacturing Market Revenue (US$ Million) & Volume (Unit) Estimates and Forecasts by Country, 2019-2031

10.4.1.1.             Brazil

10.4.1.2.             Mexico

10.4.1.3.             Rest of Latin America

10.4.2.  Latin America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Technology, (US$ Million) 2019-2031

10.4.3.  Latin America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Application, (US$ Million) 2019-2031

10.4.4.  Latin America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By End-user, 2019-2031

10.4.5.  Latin America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Deployment Options, 2019-2031

10.4.6.  Latin America Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Type(s) of Biologic(s)Manufactured, 2019-2031

10.5.     Middle East & Africa

10.5.1.  Middle East & Africa Digital Biomanufacturing Market Revenue (US$ Million) & Volume (Unit) Estimates and Forecasts by country, 2019-2031

10.5.1.1.             GCC Countries

10.5.1.2.             Israel

10.5.1.3.             South Africa

10.5.1.4.             Rest of Middle East and Africa

10.5.2.  Middle East & Africa Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Technology, (US$ Million) 2019-2031

10.5.3.  Middle East & Africa Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) By Application, (US$ Million) 2019-2031

10.5.4.  Middle East & Africa Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By End-user, 2019-2031

10.5.5.  Middle East & Africa Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Deployment Options, 2019-2031

10.5.6.  Middle East & Africa Digital Biomanufacturing Market revenue (US$ Million) & Volume (Unit) estimates and forecasts By Type(s) of Biologic(s)Manufactured, 2019-2031

Chapter 11.        Competitive Landscape

11.1.     Major Mergers and Acquisitions/Strategic Alliances

11.2.     Company Profiles

11.2.1.  3M

11.2.1.1.             Business Overview

11.2.1.2.             Key Product/Service Overview

11.2.1.3.             Financial Performance

11.2.1.4.             Geographical Presence

11.2.1.5.             Recent Developments with Business Strategy

11.2.2.  ABB

11.2.3.  Cytiva

11.2.4.  Siemens

11.2.5.  immersciobio

11.2.6.  Sanofi

11.2.7.  BIOMÉRIEUX

11.2.8.  Agilent Technologies, Inc

11.2.9.  GE Healthcare

11.2.10.              Culture Biosciences

11.2.11.              IDBS

11.2.12.              Aspen Technology Inc.

11.2.13.              Emerson Electric Co.

11.2.14.              Honeywell International Inc.

11.2.15.              SAP SE

11.2.16.              Bota Biosciences

11.2.17.              FabricNano

11.2.18.              OVO Biomanufacturing

11.2.19.              Dassault Systèmes

11.2.20.              FUJIFILM Diosynth Biotechnologies

11.2.21.              Körber Digital

11.2.22.              Merck KGaA

11.2.23.              Sartorius AG

11.2.24.              Lonza

11.2.25.              Other Prominent Players 

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8129
Security Code field cannot be blank!

Frequently Asked Questions

General Electric Company, Honeywell International Inc., SAP SE, Siemens Healthineers AG, Bota Biosciences, Culture Biosciences, e-matica srl, Exponent

The Digital Biomanufacturing Market Size is valued at 19.04 Billion in 2022 and is predicted to reach 57.69 Million by the year 2031.

The Digital Biomanufacturing Market is expected to grow at a 13.2 % CAGR during the forecast period for 2023-2031.
Get Sample Report Enquiry Before Buying